Skip to content
Explore cutting-edge technology trends, innovation strategi…

The Zimbabwean Government Turns Down ‘Unbalanced’ US Healthcare Assistance Agreement Due to Data Apprehensions

Health aid illustration
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US health deal valued at 367 million US dollars (272 million pounds) over five years because of the United States' request for confidential data.

This rejection became public after a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesman has since stated that the US was seeking health data for research and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged further dialogue to secure a agreement suitable to both sides so the country's vital HIV treatment initiative can be sustained.

Broader Background

Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were raised about the security of citizens' medical information.

Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and accountability.

According to statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"Our nation was requested to provide its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Put simply, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people should a new pandemic emerge."

National Interest and International Frameworks

Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already established through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.

"This mechanism is intended to guarantee that when a nation contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We welcome ongoing discussions with our American counterparts on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks must proceed since a large portion of the nation's Aids initiatives relied on foreign aid.

"If technical issues arise, such as those involving information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it added.

This impasse highlights the ongoing tensions between receiving vital international aid and protecting national sovereignty in an ever more data-driven world.

DR
The writer

Darin Rivera

Elena Voss is a tech strategist and writer, specializing in emerging technologies and digital transformation.

ProDynamic Havenbase

Type to search articles.